Global Cancer Vaccines Market, By Technology (Recombinant Cancer Vaccines, Whole-Cell Cancer Vaccine

Published Date: | Report Code : HC1958584

X

The Cancer Vaccines Market growth is expected to gain high momentum during the forecast period due to Increased investment and government funding in cancer vaccine development.

Cancer vaccines are being created as a technique for stopping certain kinds of cancer and as therapeutic options for treating existing cancers in a variety of oncological indications. In combination with traditional cancer therapies such as chemotherapy and surgery, or as stand-alone therapies. The high mortality rate associated with cancer and its resistance to conventional treatments such as radiation and chemotherapy has resulted in the investigation of a variety of anti-cancer immunotherapies that are associated with their use with reduced toxicity than traditional chemotherapy.

Segment Analysis:

The global cancer vaccines market is anticipated rapid growth due to the incidence of cancer increases rapidly across the globe. In 2012, around 14 million cancer instances and 8.2 million cancer fatalities were recorded by the World Health Organization. Lung, colorectal, prostate, cervical, and breast cancers were the most prevalent types. Therefore, there is a strong demand for cancer prevention and treatment vaccines. However, owing to the weak immune system of the elderly population, the increasing aging population worldwide may hamper market growth, there are opportunities that they may not be able to generate an immune response after vaccination.

The global cancer vaccines market is segmented based on technology, type, indication, and end user. By technology, this market split into recombinant cancer vaccines, whole-cell cancer vaccines, DNA cancer vaccines, and others. Based on the treatment method, it is bifurcated into preventive cancer vaccines and therapeutic cancer vaccines. Preventive vaccines or prophylactic vaccines segment is expected to high demand because these vaccines work by stopping infectious agents that cause cancer. These vaccines are similar to traditional vaccines that, by defending the body from infections, help avoid infectious diseases such as polio and measles. Based on indication, it is divided into cervical cancer, prostate cancer, and others. Based on the end user, it is categorized into pediatric and adult vaccines. The global cancer vaccines market is expected to boom in the North America region because of high cancer prevalence along with the region's advanced healthcare infrastructure.

Key Factors Impacting Market Growth:

  • The increasing number of cancer cases across globe

  • Increased investment and government funding in cancer vaccine development

  • Technological development of vaccines for cancer

Regional Analysis:

North America, Western Europe, and Asia Pacific by region are estimated to dominate the cancer vaccines market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, the government policies have been favorable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for cancer vaccines market during the forecast period. The US, Germany, France, UK, Canada, and Spain have been some the major markets in the region. Asia Pacific is estimated to register one of highest CAGR for cancer vaccines market during the forecast period. This region has witnessed strategic investments by global companies to cater the growing demand in the recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for cancer vaccines market in the region. Other regions including Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for cancer vaccines during the forecast period.

Companies Covered: Astrazeneca Plc. (Medimmune, LLC.), Glaxosmithkline Plc., Merck & Co., Inc., Sanofi Pasteur, Aduro BioTech Inc., Sanpower Group, Astellas Pharma Inc., CSL Limited, Pfizer Inc., Serum Institute of India Pvt. Ltd., Gritstone Oncology, PaxVax Corporation., Bavarian Nordic, Bharat Biotech., VBI Vaccines Inc., Novavax, Inc., Dynavax Technologies Corporation, Immunomic Therapeutics, Inc., Gamma Vaccines Pty Limited, Sinovac Biotech Ltd., Galena Biopharma, Emergent Biosolutions, Prokarium, and ImmunoBiology Ltd

Market Segmentation:

By Technology:

  • Recombinant Cancer Vaccines

  • Whole-Cell Cancer Vaccines

  • DNA Cancer Vaccines

  • Others

By Treatment Method:

  • Preventive Vaccine

  • Therapeutic Vaccine

By Indication:

  • Cervical Cancer

  • Prostate Cancer

  • Others

By End User:

  • Pediatrics

  • Adults

By Region:

  • North America

    • By Country (US, Canada, Mexico)

    • By Technology

    • By Treatment Method

    • By Indication

    • By End User

  • Western Europe

    • By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)

    • By Technology

    • By Treatment Method

    • By Indication

    • By End User

  • Eastern Europe

    • By Country (Russia, Turkey, Rest of Eastern Europe)

    • By Technology

    • By Treatment Method

    • By Indication

    • By End User

  • Asia Pacific

    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)

    • By Technology

    • By Treatment Method

    • By Indication

    • By End User

  • Middle East

    • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)

    • By Technology

    • By Treatment Method

    • By Indication

    • By End User

  • Rest of the World

    • By Region (South America, Africa)

    • By Technology

    • By Treatment Method

    • By Indication

    • By End User

Reasons To Buy This Report:

  • Market size estimation of the global cancer vaccines market on a regional and global basis

  • Unique research design for market size estimation and forecast

  • Profiling of major companies operating in the market with key developments

  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment

  • By Sub-segment

  • By Region/Country

For more information, contact: [email protected]

License Offering

Single User (PDF)

3850

Multi User (PDF)

5150

Enterprise User (PDF)

7650

 Regional Analysis

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision

Recommendations

Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy